Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ele Ferrannini

Showing results (381-390 of 408) with videos related to

Pageof 41
Sort By:
The Lancet. Diabetes & Endocrinology|July 2, 2021
Imatinib therapy for patients with recent-onset type 1 diabetes: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trialStephen E Gitelman, Brian N Bundy, Ele Ferrannini, et al.
Obesity (Silver Spring, Md.)|June 23, 2025
Tirzepatide for reduction of morbidity and mortality in adults with obesity: rationale and design of the SURMOUNT-MMO trialCarolyn S P Lam, Angel Rodriguez, Ali Aminian, et al.
Diabetes|February 5, 2013
Genetic variants associated with glycine metabolism and their role in insulin sensitivity and type 2 diabetesWeijia Xie, Andrew R Wood, Valeriya Lyssenko, et al.
Nutrients|April 14, 2017
Associations of Dietary Glucose, Fructose, and Sucrose with β-Cell Function, Insulin Sensitivity, and Type 2 Diabetes in the Maastricht StudyLouise J C J den Biggelaar, Simone J P M Eussen, Simone J S Sep, et al.
Scientific Reports|July 16, 2020
Liver nucleotide biosynthesis is linked to protection from vascular complications in individuals with long-term type 1 diabetesRuchi Jain, Türküler Özgümüş, Troels Mygind Jensen, et al.
Diabetes|January 22, 2015
Association analysis of 29,956 individuals confirms that a low-frequency variant at CCND2 halves the risk of type 2 diabetes by enhancing insulin secretionHanieh Yaghootkar, Alena Stancáková, Rachel M Freathy, et al.
Diabetes Care|February 8, 2019
International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium-Glucose Cotransporter (SGLT) InhibitorsThomas Danne, Satish Garg, Anne L Peters, et al.
The Journal of Clinical Endocrinology and Metabolism|September 18, 2020
Genome-Wide Association Analysis of Pancreatic Beta-Cell Glucose SensitivityHarshal A Deshmukh, Anne Lundager Madsen, Ana Viñuela, et al.
Cardiovascular Diabetology|January 28, 2014
Residual macrovascular risk in 2013: what have we learned?Jean-Charles Fruchart, Jean Davignon, Michel P Hermans, et al.
European Heart Journal|January 16, 2007
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)Lars Rydén, Eberhard Standl, Małgorzata Bartnik, et al.
Pageof 41

Showing results (381-390 of 408) with videos related to

Sort By:
Pageof 41
The Lancet. Diabetes & Endocrinology|July 2, 2021
Imatinib therapy for patients with recent-onset type 1 diabetes: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trialStephen E Gitelman, Brian N Bundy, Ele Ferrannini, et al.
Obesity (Silver Spring, Md.)|June 23, 2025
Tirzepatide for reduction of morbidity and mortality in adults with obesity: rationale and design of the SURMOUNT-MMO trialCarolyn S P Lam, Angel Rodriguez, Ali Aminian, et al.
Diabetes|February 5, 2013
Genetic variants associated with glycine metabolism and their role in insulin sensitivity and type 2 diabetesWeijia Xie, Andrew R Wood, Valeriya Lyssenko, et al.
Nutrients|April 14, 2017
Associations of Dietary Glucose, Fructose, and Sucrose with β-Cell Function, Insulin Sensitivity, and Type 2 Diabetes in the Maastricht StudyLouise J C J den Biggelaar, Simone J P M Eussen, Simone J S Sep, et al.
Scientific Reports|July 16, 2020
Liver nucleotide biosynthesis is linked to protection from vascular complications in individuals with long-term type 1 diabetesRuchi Jain, Türküler Özgümüş, Troels Mygind Jensen, et al.
Diabetes|January 22, 2015
Association analysis of 29,956 individuals confirms that a low-frequency variant at CCND2 halves the risk of type 2 diabetes by enhancing insulin secretionHanieh Yaghootkar, Alena Stancáková, Rachel M Freathy, et al.
Diabetes Care|February 8, 2019
International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium-Glucose Cotransporter (SGLT) InhibitorsThomas Danne, Satish Garg, Anne L Peters, et al.
The Journal of Clinical Endocrinology and Metabolism|September 18, 2020
Genome-Wide Association Analysis of Pancreatic Beta-Cell Glucose SensitivityHarshal A Deshmukh, Anne Lundager Madsen, Ana Viñuela, et al.
Cardiovascular Diabetology|January 28, 2014
Residual macrovascular risk in 2013: what have we learned?Jean-Charles Fruchart, Jean Davignon, Michel P Hermans, et al.
European Heart Journal|January 16, 2007
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)Lars Rydén, Eberhard Standl, Małgorzata Bartnik, et al.
Pageof 41